ConductScience.org, home

Paper28906353

Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies.

Weber E and 6 others. Medicine (Baltimore), 2017. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies. Papers, record 28906353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28906353

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies.
PubMed
Journal
Medicine (Baltimore)
PubMed
Year
2017
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2025-06-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weber EEmmanuelle
2Reynaud QQuitterie
3Fort RRomain
4Durupt SStéphane
5Cathébras PPascal
6Durieu IIsabelle
7Lega JCJean-Christophe

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunomodulationMajor topic
Purpura, Thrombocytopenic, IdiopathicMajor topic
Humans

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126422785Is there still a place for "old therapies" in the management of immune thrombocytopenia?Rev Med Interne2016https://conductscience.org/library/papers/26422785PubMed
22099421Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.Postgrad Med J1990https://conductscience.org/library/papers/2099421PubMed
310789670Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.JAMA2000https://conductscience.org/library/papers/10789670PubMed
41644159Recombinant alpha-2b interferon in refractory idiopathic immune thrombocytopenia.Eur J Haematol1992https://conductscience.org/library/papers/1644159PubMed
51799483alpha Interferon therapy in the treatment of idiopathic thrombocytopenic purpura.Eur J Cancer1991https://conductscience.org/library/papers/1799483PubMed
615642672Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.Haematologica2005https://conductscience.org/library/papers/15642672PubMed
722190262Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.Am J Hematol2012https://conductscience.org/library/papers/22190262PubMed
812111919Quantifying heterogeneity in a meta-analysis.Stat Med2002https://conductscience.org/library/papers/12111919PubMed
93107321Danazol therapy in refractory chronic immune thrombocytopenic purpura.Acta Haematol1987https://conductscience.org/library/papers/3107321PubMed
1024152261HLA-B*13:01 and the dapsone hypersensitivity syndrome.N Engl J Med2013https://conductscience.org/library/papers/24152261PubMed
113605896Low-dose danazol therapy in idiopathic thrombocytopenic purpura.Ann Intern Med1987https://conductscience.org/library/papers/3605896PubMed
123937415Danazol in idiopathic thrombocytopenic purpura.Acta Haematol1985https://conductscience.org/library/papers/3937415PubMed
1321325604The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.Blood2011https://conductscience.org/library/papers/21325604PubMed
1419846889International consensus report on the investigation and management of primary immune thrombocytopenia.Blood2010https://conductscience.org/library/papers/19846889PubMed
1524254965Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.Am J Hematol2014https://conductscience.org/library/papers/24254965PubMed
161581224Recombinant alpha 2b interferon in the treatment of refractory autoimmune thrombocytopenic purpura.Br J Haematol1992https://conductscience.org/library/papers/1581224PubMed
179793270Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura.Haematologica1998https://conductscience.org/library/papers/9793270PubMed
1812651980Danazol-induced hepatocellular carcinoma.QJM2003https://conductscience.org/library/papers/12651980PubMed
196682484Danazol for the treatment of idiopathic thrombocytopenic purpura.N Engl J Med1983https://conductscience.org/library/papers/6682484PubMed
2010861324A comparison of observational studies and randomized, controlled trials.N Engl J Med2000https://conductscience.org/library/papers/10861324PubMed

See all 47 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
39627479Immune thrombocytopenia in patients with systemic lupus erythematosus.Clin Rheumatol2025https://conductscience.org/library/papers/39627479PubMed
39040719Severe Thrombocytopenia Secondary to Systemic Lupus Erythematosus With Antiphospholipid Antibodies in a Middle-Aged Woman.Cureus2024https://conductscience.org/library/papers/39040719PubMed
38608258The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia.Blood Adv2024https://conductscience.org/library/papers/38608258PubMed
31897887Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision.Int J Hematol2020https://conductscience.org/library/papers/31897887PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PC5091PubTator's text mininghttps://conductscience.org/library/genes/5091NCBI Gene
THPO7066PubTator's text mininghttps://conductscience.org/library/genes/7066NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28906353

GET https://conductscience.org/api/papers/v1/28906353/references?page=2